SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. Logo

SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.

A contract research organization providing preclinical and clinical services for medical industries.

2395 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
鹿児島市宮之浦町2438番地
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Shin Nippon Biomedical Laboratories, Ltd. (SNBL), established in 1957 as Japan's pioneering contract research organization (CRO), offers comprehensive drug development support services. The company specializes in preclinical and nonclinical safety studies, translational research, and clinical trial services for the pharmaceutical, medical device, and regenerative medicine industries. A key area of innovation includes the research and development of its proprietary nasal delivery system (NDS), the μco™ System. SNBL's mission is to free patients from suffering by supporting the creation of advanced medical technologies and novel pharmaceuticals.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-30 08:58
Post-Annual General Meeting Information
臨時報告書
Japanese 24.7 KB
2025-06-27 07:46
Regulatory News Service
確認書
Japanese 8.2 KB
2025-06-27 07:40
Regulatory News Service
内部統制報告書-第52期(2024/04/01-2025/03/31)
Japanese 23.5 KB
2025-06-27 07:32
Annual Report
有価証券報告書-第52期(2024/04/01-2025/03/31)
Japanese 3.0 MB
2024-11-06 04:17
Report Publication Announcement
確認書
Japanese 10.8 KB
2024-11-06 04:11
Interim Report
半期報告書-第52期(2024/04/01-2025/03/31)
Japanese 253.7 KB
2024-06-26 04:52
Regulatory News Service
臨時報告書
Japanese 24.6 KB
2024-06-25 07:06
Regulatory News Service
確認書
Japanese 8.2 KB
2024-06-25 06:57
Governance Information
内部統制報告書-第51期(2023/04/01-2024/03/31)
Japanese 22.5 KB
2024-06-25 06:38
Annual Report
有価証券報告書-第51期(2023/04/01-2024/03/31)
Japanese 3.2 MB
2024-02-02 03:40
Report Publication Announcement
確認書
Japanese 10.8 KB
2024-02-02 03:39
Quarterly Report
四半期報告書-第51期第3四半期(2023/10/01-2023/12/31)
Japanese 203.9 KB
2023-11-07 07:18
Report Publication Announcement
確認書
Japanese 10.8 KB
2023-11-07 07:08
Quarterly Report
四半期報告書-第51期第2四半期(2023/07/01-2023/09/30)
Japanese 248.6 KB
2023-08-02 05:34
Report Publication Announcement
確認書
Japanese 10.8 KB

Automate Your Workflow. Get a real-time feed of all SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Offers performance-based advertising and CPA solutions via Japan's largest affiliate network.
Japan 2461
Back-office outsourcing & consulting in accounting, finance, and HR for SMEs & sole proprietors.
Japan 4771
FRIENDLY CORPORATION Logo
Offers digital solutions for business growth: web production, marketing, e-commerce, & incubation.
Japan 8209
FunPep Company Limited Logo
Biotech firm developing peptide-based therapeutics, cosmetics, and medical devices.
Japan 4881
GECOSS CORPORATION Logo
Leases and sells temporary steel materials and equipment for large construction projects.
Japan 9991
GENDAI AGENCY INC. Logo
Advertising agency providing marketing and promotions for the pachinko industry.
Japan 2411
Geneuro Logo
Developing antibody therapies targeting pathogenic HERVs for MS and post-COVID syndromes.
Switzerland GEM
Developing long-acting immunotherapeutics for immuno-oncology and rare diseases.
South Korea 095700
GENFLOW BIOSCIENCES PLC Logo
Develops gene therapies to slow aging and treat age-related diseases in humans and dogs.
United Kingdom GENF
GENINUS Inc. Logo
AI-powered genomic and multi-omics analysis for precision medicine and clinical partners.
South Korea 389030

Talk to a Data Expert

Have a question? We'll get back to you promptly.